We are committed to providing a website that is accessible to the widest possible audience. To do so, we are actively working with consultants to update the website by increasing its accessibility and usability by persons who use assistive technologies
such as automated tools, keyboard-only navigation, and screen readers.
We are working to have the website conform to the relevant standards of the Section 508 Web Accessibility Standards developed by the United States Access Board, as
well as the World Wide Web Consortium's (W3C) Web Content Accessibility Guidelines 2.1. These standards and guidelines explain how to make web content more accessible for people with disabilities. We believe that conformance with these standards and
guidelines will help make the website more user friendly for all people.
Our efforts are ongoing. While we strive to have the website adhere to these guidelines and standards, it is not always possible to do so in all areas of the website.
If, at any time, you have specific questions or concerns about the accessibility of any particular webpage, please contact WebsiteAccess@tenethealth.com so that we may be of assistance.
Consultative Cancer Conferences, or “Tumor Boards”, play a key role in the treatment of patients diagnosed with cancer. Chaired by Edwin Hayashi, MD, this team of surgeons, medical oncologists, radiation oncologists, pathologists, and radiologists meet twice monthly to review unusual, aggressive, and/or complex cancer cases.
Meetings are held the first and third Wednesday of every month. During each session, the patient’s history, pertinent lab results, x-rays/imaging, and pathology are provided to this multidisciplinary team of physicians. These physicians, as a team, then determine the best course of action for each patient.
Sierra Vista has seen a steady increase in the number of cases presented each year, and equally important there has been an increase in the number of physicians attending the tumor boards. In 2015, over 185 Sierra Vista patients received the benefit of tumor board evaluation.
A special acknowledgement goes to the many physicians who participate in these cancer conferences: